- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 22nd, 2006
BioLok International Inc. (OTC Bulletin Board: BLLI), the manufacturer and worldwide distributor of leading-edge dental implant technology, today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market BoneGen-TR. The FDA clearance, which could have taken up to 90 days or longer, was granted 5 weeks after BioLok made its submission.
BoneGen-TR from BioLok, a pioneer in merging technological innovation and cell biology, is a clinically safe, nano-composite, time release calcium sulfate product used for bone regeneration, augmentation, and as a soft tissue barrier in Implantology, Periodontology, Endodontics and Oral Surgery.
|Related News Press|
Nuclear pores captured on film: Using an ultra fast-scanning atomic force microscope, researchers from the University of Basel have filmed 'living' nuclear pore complexes at work for the first time May 3rd, 2016
Exploring phosphorene, a promising new material April 29th, 2016
Atomic magnets using hydrogen and graphene April 27th, 2016